189 related articles for article (PubMed ID: 10744934)
1. Is dissection of the internerve tissue during axillary lymphadenectomy for breast cancer necessary?
Mostafa A; Mokbel K; Engledow A; Leris AC; Choy C; Wells C; Carpenter R
Eur J Surg Oncol; 2000 Mar; 26(2):153-4. PubMed ID: 10744934
[TBL] [Abstract][Full Text] [Related]
2. Value of internerve tissue dissection during axillary lymphadenectomy for early breast cancer.
Rabie AS; Eldweny HI; Abdel Maksoud IG; Elbasmy AA
J Egypt Natl Canc Inst; 2007 Dec; 19(4):249-53. PubMed ID: 19672288
[TBL] [Abstract][Full Text] [Related]
3. Interneural tissue clearance in axillary dissection for breast cancer: What is the importance?
Patel PK; Sinha AK; Saini S
Indian J Cancer; 2017; 54(3):539-542. PubMed ID: 29798954
[TBL] [Abstract][Full Text] [Related]
4. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
7. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
Petrik DW; McCready DR; Sawka CA; Goel V
J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062
[TBL] [Abstract][Full Text] [Related]
8. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
[TBL] [Abstract][Full Text] [Related]
9. [Exploration of the extent of axillary dissection for patients with node positive primary breast cancer].
Ouyang T; Li JF; Wang TF; Lin BY
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):298-300. PubMed ID: 15842936
[TBL] [Abstract][Full Text] [Related]
10. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
11. Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy.
Spillane AJ; Brennan ME
Eur J Surg Oncol; 2009 Apr; 35(4):380-6. PubMed ID: 18757165
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
13. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
14. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
[TBL] [Abstract][Full Text] [Related]
15. Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial.
Carcoforo P; Soliani G; Maestroni U; Donini A; Inderbitzin D; Hui TT; Lefor A; Avital I; Navarra G
J Am Coll Surg; 2003 Mar; 196(3):365-9. PubMed ID: 12648685
[TBL] [Abstract][Full Text] [Related]
16. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
[TBL] [Abstract][Full Text] [Related]
17. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
18. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
19. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
Ahlgren J; Holmberg L; Bergh J; Liljegren G
Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node biopsy or limited oriented axillary dissection (LOAD) in early breast cancer.
Salmon RJ; Marcolet A; Vieira M; Languille O
Eur J Surg Oncol; 2005 Nov; 31(9):949-53. PubMed ID: 15893907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
